AstraZeneca PLC
1507.50
10-1月-25 11:24:55
15 分の遅延
株式
-1.25
-0.08%
本日の幅
1495.50 - 1510.50
ISIN
N/A
ソース
Cboe
-
AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance
23 9 2024 03:29:23 提供 NASDAQ US Markets
-
AZN : IMFINZI Regimen Reduces Death Risk By 25% In Late-Stage Muscle-Invasive Bladder Cancer Trial
15 9 2024 13:57:59 提供 NASDAQ US Markets
-
SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally
10 9 2024 11:30:45 提供 NASDAQ US Markets
-
AstraZeneca :Dato-DXd Fails To Significantly Improve Overall Survival In Phase III Lung Cancer Trial
09 9 2024 21:50:46 提供 NASDAQ US Markets
-
Chinese Authorities Detain AstraZeneca Employees
05 9 2024 17:39:29 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
03 9 2024 03:15:42 提供 NetDania Notify
-
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
30 8 2024 09:35:45 提供 NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
30 8 2024 06:41:41 提供 NetDania Notify
-
Interesting AZN Put And Call Options For November 15th
23 8 2024 11:14:24 提供 NASDAQ Stocks
-
AZN: Enhertu Gets US Breakthrough Therapy Designation For HER2 Low/Ultralow Metastatic Breast Cancer
19 8 2024 03:08:28 提供 NASDAQ US Markets
-
AstraZeneca's Imfinzi Gets US Approval For Resectable Early-stage Lung Cancer
16 8 2024 03:28:46 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
16 8 2024 03:17:04 提供 NetDania Notify
-
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
15 8 2024 07:38:12 提供 NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
15 8 2024 03:15:16 提供 NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
13 8 2024 03:19:30 提供 NetDania Notify
-
Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo
07 8 2024 10:27:01 提供 NASDAQ Stocks
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 8 2024 10:42:17 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 7 2024 08:07:19 提供 NetDania Notify
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 7 2024 03:38:02 提供 NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 7 2024 03:05:05 提供 NASDAQ US Markets